Published March 10, 2021
| Version v1
Report
Open
RETURNING INDIVIDUAL CLINICAL TRIAL DATA BACK TO PARTICIPANTS
Creators
- 1. ReveraGen Biopharma
- 2. World Duchenne Organisation
- 3. Ceratium Ltd
Description
A white paper addressing the ethical and technical challenges of returning meaningful individual clinical trial results to trial participants
Files
VisionDMD_White-Paper_Returning-Individual-Clinical-Trial-Results-Back-To-Patients_Consortium-final.pdf
Files
(909.0 kB)
Name | Size | Download all |
---|---|---|
md5:4492a0017aa1b56dc7a9e8f111ea2143
|
909.0 kB | Preview Download |